Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body’s needs for blood and oxygen. It is caused by many conditions that damage the heart muscle such as; coronary artery disease, heart attack, high blood pressure, congested lungs and others.
In this condition, a transplant is one option, but there aren't nearly enough donor hearts to meet the need. For example; As of April 17, 2018, according to OPTN data; nearly 4,000 people across the U.S. are on the waiting list for donor hearts, including 400 Texans. Unfortunately, a significant number of patients die before suitable donor hearts become available for transplantation.
The leading market players mainly include:
Some major key players for Global Heart Pump Device Market are Terumo Europe NV, Abbott Laboratories, Medtronic, CardiacAssist, Inc., SynCardia Systems, LLC, Berlin Heart Gmbh, HeartWare, Jarvik Heart, Inc., Thoratec Corporation, Abiomed, Inc., Teleflex Incorporated, Reliant Heart, Inc. and others.
The detailed segments and sub-segment of the market are explained below:
By Product Type:
- Ventricular Assist Devices
- Total Artificial Heart
- Intra-Aortic Balloon Pumps
By Device Type:
- Implantable Heart Pump Devices
- Extracorporeal Heart Pump Devices
- Destination Therapy
- Hospitals & Clinics
- Research Institutes
- Ambulatory Surgical Centers
Get Full information of This Report@